Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 May;75(10):4878-88.
doi: 10.1128/JVI.75.10.4878-4888.2001.

Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells

A Abendroth  1 , I Lin, B Slobedman, H Ploegh, A M Arvin
Affiliations

Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells

A Abendroth et al. J Virol. 2001 May.

Abstract

We sought to examine the effects of varicella-zoster virus (VZV) infection on the expression of major histocompatibility complex class I (MHC I) molecules by human fibroblasts and T lymphocytes. By flow cytometry, VZV infection reduced the cell surface expression of MHC I molecules on fibroblasts significantly, yet the expression of transferrin receptor was not affected. Importantly, when human fetal thymus/liver implants in SCID-hu mice were inoculated with VZV, cell surface MHC I expression was downregulated specifically on VZV-infected human CD3+ T lymphocytes, a prominent target that sustains VZV viremia. The stage in the MHC I assembly process that was disrupted by VZV in fibroblasts was examined in pulse-chase and immunoprecipitation experiments in the presence of endoglycosidase H. MHC I complexes continued to be assembled in VZV-infected cells and were not retained in the endoplasmic reticulum. In contrast, immunofluorescence and confocal microscopy showed that VZV infection resulted in an accumulation of MHC I molecules which colocalized to the Golgi compartment. Inhibition of late viral gene expression by treatment of infected fibroblasts with phosphonoacetic acid did not influence the modulation of MHC I expression, nor did transfection of cells with plasmids expressing immediate early viral proteins. However, cells transfected with a plasmid carrying the early gene ORF66 did result in a significant downregulation of MHC I expression, suggesting that this gene encodes a protein with an immunomodulatory function. Thus, VZV downregulates MHC I expression by impairing the transport of MHC I molecules from the Golgi compartment to the cell surface; this effect may enable the virus to evade CD8+ T-cell immune recognition during VZV pathogenesis, including the critical phase of T-lymphocyte-associated viremia.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
FACS analysis of MHC I molecules, transferrin receptor (CD71), and VZV proteins on VZV-infected cells. HFFs were either infected with VZV for 24 h (B and E) or mock infected (A and D), and cell preparations were stained with antibodies and fluorescent conjugates to MHC I and VZV proteins (A and B) or to transferrin receptor and VZV proteins (D and E). The percentages of VZV+ and VZV− cell populations expressing cell surface MHC I molecules (C) and transferrin receptor (F) are shown. (G) Percentage of VZV+ and VZV− cell populations expressing cell surface MHC I molecules. HFF, MeWo, and MRC-5 cells were infected with VZV for 24 h and stained with antibodies and fluorescent conjugates to MHC I and VZV proteins and analyzed by flow cytometry.
FIG. 2
FIG. 2
FACS analysis of MHC I and VZV proteins on VZV-infected human T lymphocytes. SCID-hu thymus/liver implants were inoculated with VZV- or mock-infected cells, and 7 days later cell preparations were stained with antibodies and fluorescent conjugates to MHC I and VZV proteins and CD3. CD3+ T lymphocytes were gated and analyzed for MHC I and VZV antigen expression. A typical FACS plot of MHC I and VZV antigens from mock- (A) and VZV-infected (B) thymus/liver implants is shown. The percentage of CD3+/VZV+ cells was determined for each mouse (C). The percentage of VZV+ and VZV− human CD3+ T-cell populations expressing cell surface MHC I molecules is shown (D).
FIG. 3
FIG. 3
Immunofluorescent staining of intracellular MHC I and VZV antigens in VZV-infected cells. VZV-infected cells were fixed, permeabilized, and incubated with VZV-immune human serum and an anti-MHC I MAb, which were detected using Texas red-conjugated anti-human IgG and FITC-conjugated anti-mouse IgG antibodies. VZV antigen staining was detected in the majority of VZV-infected cells (A). Intense perinuclear MHC I staining was detected in VZV-infected cells (B, arrow), whereas diffuse cytoplasmic MHC I staining was detected in VZV-negative cells (B, arrowhead). The yellow color indicates colocalization of VZV and MHC I proteins in VZV-infected cells (C).
FIG. 4
FIG. 4
Biochemical analysis of the synthesis and transport of MHC I molecules in VZV-infected cells. VZV- and mock-infected cells were labeled with [35S]methionine-cysteine and then chased for 0, 1, 2, and 3 h. Total cell lysates were immunoprecipitated with W6/32, and immune complexes were treated either with (+) or without (−) endo H. The MHC I endo H-resistant (R) and -sensitive (S) forms are indicated.
FIG. 5
FIG. 5
ConA, ceramide, and MHC I immunofluorescent staining of VZV-infected cells. VZV-infected cells were labeled with Texas red-conjugated ConA (A to C) or Texas red-conjugated BODIPY-ceramide (D to F), fixed, permeabilized, and stained with anti-MHC I MAb and FITC-conjugated anti-mouse IgG antibody. Fluorescent images were overlayed to assess colocalization (C and F). The yellow color represents colocalization of MHC I molecules and the fluorescent marker of the Golgi compartment (F). No colocalization was detected with the fluorescent ER marker (C).
FIG. 6
FIG. 6
Biochemical analysis of the synthesis of MHC I molecules in VZV-infected cells. VZV- and mock-infected cells were labeled with [35S]methionine-cysteine and then chased for 1 h. Total cell lysates were immunoprecipitated with rabbit anti-heavy chain (αHC) or W6/32 antibody, and immune complexes were treated either with (+) or without (−) endo H. The MHC I endo H-resistant (R) and -sensitive (S) forms are indicated. β2m and the coimmunoprecipitating protein seen in VZV-infected cells are indicated.
FIG. 7
FIG. 7
Analysis of MHC I downregulation in VZV- and mock-infected cells treated with the viral DNA inhibitor PAA. (A) Western blot of viral gC was performed on total cell lysates from mock-infected cells (lane 1), mock-infected cells with PAA (lane 2), VZV-infected cells at the time of inoculation onto uninfected cells (lane 3), and VZV-infected cells in the absence (lane 4) or presence (lane 5) of PAA at 24 h postinfection. (B) The percentage of VZV+ and VZV− cell populations expressing cell surface MHC I molecules. Cells were infected with VZV in the absence or presence of PAA for 24 h and stained with antibodies and fluorescent conjugates to MHC I and VZV proteins and analyzed by flow cytometry.
FIG. 8
FIG. 8
Analysis of MHC I downregulation in cells transfected with plasmids expressing VZV proteins. HFFs were transiently transfected with plasmids expressing VZV ORF4, ORF10, ORF47, ORF61, ORF62, ORF63, and ORF66 or a parental control plasmid (control). At 48 h posttransfection cell preparations were stained for MHC I expression. Data are shown as the mean fluorescence intensities of specific cell surface MHC I staining.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abendroth A, Slobedman B, Lee E, Wallace M, Mellins E, Arvin A. Modulation of major histocompatibility complex class II expression by varicella-zoster virus. J Virol. 2000;74:1900–1907. - PMC - PubMed
    1. Ahn K, Angulo A, Ghazal P, Peterson P A, Yang Y, Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA. 1996;93:10990–10995. - PMC - PubMed
    1. Ahn K, Gruhler A, Galocha B, Jones T R, Wiertz E J, Ploegh H L, Peterson P A, Yang Y, Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 1997;6:613–621. - PubMed
    1. Ahn K, Meyer T H, Uebel S, Sempe P, Djaballah H, Yang Y, Peterson P A, Fruh K, Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 1996;15:3247–3255. - PMC - PubMed
    1. Arvin A. Varicella-zoster virus. In: Fields B N, Knipe D M, Howley P M, editors. Fields virology. 3rd ed. Philadelphian, Pa: Lippincott-Raven Publishers; 1996. pp. 2547–2586.

Publication types

MeSH terms